Metabolic memory plays a key role in breast cancer relapse
Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists
EMBOEncounters:
Biannual EMBO magazine
EMBO newsletters
- Contact
EMBO Communications
You are here:
Category: Press releases
Increasing participation throughout Europe
EMBO adds activities to its programmes and launches new funding schemes for researchers in or going to one of nine countries
Fiona Watt appointed as EMBO Director
The British cell biologist will take up the appointment in early 2022
EMBO Gold Medal 2021 awarded to Andrea Ablasser
With the award, EMBO recognizes outstanding achievements of scientists under the age of 40 in Europe.
EMBO announces 64 newly elected members
EMBO announces the election of 64 life scientists to its membership.
Molly Stevens receives the FEBS | EMBO Women in Science Award 2021
EMBO and FEBS announce Molly Stevens of Imperial College London, UK, as the recipient of the FEBS | EMBO Women in Science Award 2021.
Bernd Pulverer appointed Chief Editor of EMBO Reports
EMBO Press announces the appointment of Bernd Pulverer, Head of Scientific Publishing at EMBO, as Chief Editor of EMBO Reports.
Facundo Batista appointed Chief Editor of The EMBO Journal
EMBO Press announces the appointment of immunologist Facundo Batista, PhD, as Chief Editor of The EMBO Journal.
EMBO Installation Grants support eight early-career scientists to establish independent laboratories
EMBO is pleased to announce the award of Installation Grants to eight scientists in the early stages of setting up their independent laboratories in Lithuania, Poland, Portugal and Turkey.
SARS-CoV-2 infection demonstrated in a human lung bronchioalveolar tissue model
Development of an in vitro human-derived tissue model for studying virus infection and disease progression in the alveolar cells of the lungs responsible for oxygen and carbon dioxide exchange with the blood might enable the study of possible therapies for acute respiratory distress syndrome (ARDS) triggered by SARS-CoV-2.
